Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Mesothelioma and SETD2[original query] |
|---|
| Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma. Investigational new drugs 2021 Mar . Zauderer Marjorie G, Alley Evan W, Bendell Johanna, Capelletto Enrica, Bauer Todd M, Callies Sophie, Szpurka Anna M, Kang Suhyun, Willard Melinda D, Wacheck Volker, Varghese Anna |
| [Expression and clinical significance of SETD2 in maligant pleural mesothelioma]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 2021 3 39 (2): 91-98. Yu M, Yu M, Zhu L J, Yuan X Y, Zhang |
| Genomic landscape of pleural and peritoneal mesothelioma tumours. British journal of cancer 2022 Sep . Hiltbrunner Stefanie, Fleischmann Zoe, Sokol Ethan S, Zoche Martin, Felley-Bosco Emanuela, Curioni-Fontecedro Alessand |
- Page last reviewed:Feb 1, 2024
- Content source: